Week In Review: Livzon Leads $26 Million Funding Of Cynvenio
June 20, 2015 at 17:48 PM EDT
Cynvenio is developing LiquidBiopsy, a technology that performs genomic analyses of circulating tumor cells from whole blood. Last month, Livzon said it invested $10m in Cynvenio with an additional $10m pledged for the future.